AlphaLife Sciences
PrivateLast Round
Accelerator
Sep 28, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AlphaLife Sciences operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was an Accelerator round in September 2023.
AlphaLife Sciences is a software company that provides a GenAI-powered platform to automate the clinical research process for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, NLP & Conversational AI, Document Management, Medical AI, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlphaLife Sciences Comparables
Compare AlphaLife Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artos | 88% | |
| Narrativa | 86% | |
| Yseop | 84% |
For institutional investors. Book with your work email.
AlphaLife Sciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AlphaLife Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| B Capital Group | VC Round |
| Hankang Capital | VC Round |
| Johnson & Johnson Innovation - JLABS | Accelerator |
| Nvidia Inception | Accelerator |
| Microsoft for Startups Pegasus Program | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Partnered with Microsoft, Google, and Johnson & Johnson.
- Jan 22, 2026
Grew 32% QoQ, from 22 to 29 employees.
For institutional investors. Book with your work email.
AlphaLife Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlphaLife Sciences's valuation, stock price, and market status.
Is AlphaLife Sciences a public or private company?
AlphaLife Sciences is a private company.
What is the current stock price of AlphaLife Sciences?
AlphaLife Sciences is a private company, so its shares have no public market price. Caplight tracks AlphaLife Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlphaLife Sciences worth (valuation)?
Valuation information for AlphaLife Sciences is not publicly available.
Can I buy AlphaLife Sciences stock?
AlphaLife Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlphaLife Sciences's last funding round?
AlphaLife Sciences's most recent funding round was Accelerator on September 28, 2023.
Who are the main investors in AlphaLife Sciences?
Key investors in AlphaLife Sciences include B Capital Group, Hankang Capital, Johnson & Johnson Innovation - JLABS, Nvidia Inception, Microsoft for Startups Pegasus Program.
Will AlphaLife Sciences IPO soon?
No public IPO plans have been announced for AlphaLife Sciences.
How can I track AlphaLife Sciences secondary market activity?
Caplight tracks bids, offers, and trades in AlphaLife Sciences's shares on secondary markets.